Fever Tree Upgraded from Hold to Buy with Target Price Hike

12 days ago

Louise Moon

"Yes, this is from Jeff. Um Jeffre has upgraded Fever Tree from a hold to a buy and hiked their target price, calling them uh a more refreshing growth story. They're predicting better margins, higher cash returns going forward. Saying that they were really focusing on the recent deal between Fever Tree and Coors in the US and saying that this will deliver bigger scale and capability in the US. It will derisk the supply chain. Um, and they also noted that Fever Tree's marketing spend is set to double. That will boost their awareness. So, that's pushing shares higher this morning."

Jeff has upgraded Fever Tree from hold to buy by raising the target price and emphasizing its growth potential. The analyst highlights catalysts such as a strategic deal with Coors, expected better margins, and a doubling of marketing spend which are all anticipated to improve scale, derisk the supply chain, and elevate share performance.

Related Stocks